UNSPSC 51111805: Goserelin

This classification denotes a gonadotropin-releasing hormone analog with the molecular formula C59H84N18O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0F65R8P09N, chemically known as luteinizing hormone-releasing factor (pig), 6-(o-(1,1-dimethylethyl)-d-serine)-10-deglycinamide-, 2-(aminocarbonyl)hydrazide but generally known as goserelin, which bears US NIH Compound Identifier 47725. European Medicines Agency schedules Goserelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07962MIG.

UNSPSC 51111805 Goserelin is a Commodity code identifying a synthetic gonadotropin-releasing hormone agonist used in oncology and endocrinology treatment protocols, procured by state and local health systems, correctional facilities, and public hospitals to manage hormone-responsive cancers and certain endocrine conditions. State and local buyers use this code to specify a particular pharmaceutical agent rather than a broader drug category, enabling precise inventory management and formulary compliance across institutional healthcare networks. Issuing bodies include state health departments, county hospital systems, municipal public health agencies, and state correctional departments that maintain formularies and pharmaceutical supply chains for patient care and inmate medical services.

The source material provides no recent state and local contract opportunities tagged to this code. Without posted solicitations, RFQs, IFBs, or ITBs naming goserelin procurement, geographic activity patterns and representative buyer behavior cannot be characterized. Firms pursuing this code should monitor state Medicaid agencies, state prison health services procurement offices, and county hospital cooperative purchasing vehicles for pharmaceutical supply RFQs and IFBs, particularly in jurisdictions with large correctional or safety-net hospital networks.